نتایج جستجو برای: chronic myeloid leukemia

تعداد نتایج: 744967  

2012
Sherry Pierce Naveen Pemmaraju Hagop Kantarjian Jianqin Shan Elias Jabbour Alfonso Quintas-Cardama Srdan Verstovsek Farhad Ravandi William Wierda Susan O’Brien Jorge Cortes

©F err t St ort i F un da tio n

Journal: :Cell 2004
George Q. Daley

Chronic myeloid leukemia is one of the commonest hematological malignancies seen in clinical practice. It is the result of abnormal and excess cell proliferation due to de-regulated bcr-abl tyrosine kinase activity as a result of Philadelphia chromosome. The present article discusses the various options available to treat the disorder. Allogeneic stem cell transplant remains the gold standard a...

Journal: :Nihon rinsho. Japanese journal of clinical medicine 2014
Noriko Usui

More than 10 years have passed since imatinib as a first developed BCR-ABL tyrosine kinase inhibitor (TKI) introduced in treatment of patients with chronic myeloid leukemia (CML). In globally, there are tremendous numbers of patients on imatinib therapy. Based upon randomized trials comparing second generation TKIs such as dasatinib and nilotinib versus imatinib, both TKIs produce faster and de...

2017
Sabhi Rahman Al-Shaimaa Al-hallaj Atef Nedhi Gmal Gmati khadega Ahmed Haya Al Jama Thadeo Trivilegio Abdullah Mashour Ahmad Al Askar Mohamed Boudjelal

Disregulation of genes making up the mammalian circadian clock has been associated with different forms of cancer. This study aimed to address how the circadian clock genes behave over the course of treatment for both the acute and chronic forms of leukemia and whether any could be used as potential biomarkers as a read-out for therapeutic efficacy. Expression profiling for both core and ancill...

2014
Delphine Rea Tristan Mirault Thomas Cluzeau Jean - François Gautier François Guilhot Hervé Dombret Emmanuel Messas

ary CVD prevention. In addition, the mechanism by which nilotinib may cause or aggravate pathological processes involved in occlusive arterial diseases is currently unknown. Nilotinib has been demonstrated to induce metabolic disturbances, such as hyperglycemia in a substantial proportion of patients, via a mechanism that may involve insulin resistance. As high blood cholesterol is a major risk...

Journal: :Haematologica 2014
Robert R West Amy P Hsu Steven M Holland Jennifer Cuellar-Rodriguez Dennis D Hickstein

Inherited or sporadic heterozygous mutations in the transcription factor GATA2 lead to a clinical syndrome characterized by non-tuberculous mycobacterial and other opportunistic infections, a severe deficiency in monocytes, B cells and natural killer cells, and progression from a hypocellular myelodysplastic syndrome to myeloid leukemias. To identify acquired somatic mutations associated with m...

Journal: :Blood 1981
M Koya T Kanoh H Sawada H Uchino K Ueda

Adenosine deaminase (ADA) and ecto-5'-nucleotidase (5'-N) activities were examined in peripheral leukocytes from patients with leukemias, including nine patients with chronic myeloid leukemia (CML) in blast crisis. Four of none cases of CML in blast crisis were myeloid and the remaining lymphoid morphologically. The diagnosis of CML in lymphoid blast crisis was further contributed by the measur...

2015
Neelam WAdhWA Ruquiya AFRoSe Deepa NebhNANi Neelam WADhWA

Myeloid sarcoma, considered to herald the onset of a blast crisis in the setting of chronic myeloproliferative neoplasm/dysplasia, typically presents during the course of the disorder. Cutaneous involvement is uncommon and lesions on genital skin are seldom seen. We present a case of a well-differentiated myeloid sarcoma in the penile foreskin in an apparently healthy 29-year-old male presentin...

Journal: :iranian journal of allergy, asthma and immunology 0
ali rashidi–nezhad department of medical genetics, faculty of medicine, tehran university of medical sciences, tehran, cyrus azimi department of medical genetics, faculty of medicine, tehran university of medical sciences, tehran, kamran alimoghaddam hematology–oncology and bmt research center, shariati hospital, tehran university of medical science ardeshir ghavamzadeh hematology–oncology and bmt research center, shariati hospital, tehran university of medical science arash hossein-nezhad endocrinology and metabolism research center, shariati hospital, tehran university of medical scienc pantea izadi department of medical genetics, faculty of medicine, tehran university of medical sciences, tehran,

some of the genotypes of cytokines are associated with acute graft versus host disease after bone marrow transplantation. the purpose of the present investigation was to find out the possible association between transforming growth factor beta-1 (tgf-β1) codon 25 polymorphism (rs:1800471) and acute graft versus host disease (agvhd) after bone marrow transplantation from the sibling with the sim...

2012
Louis J. DeGennaro Jerald P. Radich

Results The rate of major molecular responses by 24 months in patients on imatinib 400 mg/day was significantly higher in those with high OCT-1 activity than in those with low OCT-1 activity (low OCT-1 activity, 57% of patients; high OCT-1 activity, 100%; P<0.001); the corresponding difference in patients treated with imatinib 800 mg/day did not reach statistical significance (low OCT-1 activit...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید